<qa>  What is the name of the protocol designed to evaluate the activity of targeted therapy in anaplasticThis is an, open-label, protocol designed to evaluate the activity of targeted therapy in anaplasticundifferentiated thyroid cancer. Arm A will evaluate ATCUTC with mutations or rearrangements detected in the ALK gene. 